Teva Pharma Industries Stock Investor Sentiment
| TEVA Stock | USD 16.25 0.38 2.29% |
About 62% of Teva Pharma's investor base is looking to short. The analysis of overall sentiment of trading Teva Pharma Industries stock suggests that many investors are alarmed at this time. The current market sentiment, together with Teva Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharma Industries stock news signals to limit their universe of possible portfolio assets.
Comfort Level 38
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Teva Pharma's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Teva Pharma Industries.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Teva Historical Sentiment
Although Teva Pharma's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Teva, such as negative comments on social media and news outlets, may cause fear in the market and push Teva Pharma's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Teva.
Teva |
Teva Pharma Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Teva Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Teva Pharma Industries Historical Investor Sentiment
Investor biases related to Teva Pharma's public news can be used to forecast risks associated with an investment in Teva. The trend in average sentiment can be used to explain how an investor holding Teva can time the market purely based on public headlines and social activities around Teva Pharma Industries. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Teva Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Teva Pharma and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Teva Pharma news discussions. The higher the estimate score, the more favorable the investor's outlook on Teva Pharma.
Far too much social signal, news, headlines, and media speculation about Teva Pharma that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharma alpha.
Teva Pharma Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Insider Trading | 11/29/2024 |
2 | Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook | 01/13/2025 |
3 | FDA Warns Of Severe Allergic Reaction Risk With Tevas Multiple Sclerosis Drug | 01/23/2025 |
4 | Acquisition by Eliyahu Kalif of 183169 shares of Teva Pharma subject to Rule 16b-3 | 01/28/2025 |
5 | Teva Pharm tops quarterly estimates but 2025 earnings outlook falls short - Reuters | 01/29/2025 |
6 | Q4 2024 Teva Pharmaceutical Industries Ltd Earnings Call Transcript | 01/31/2025 |
7 | Aging Population Fuels Nocturia Market Growth, Projected to Reach US 8.5 Billion by 2034 Latest Research Report by TMR | 02/04/2025 |
8 | Teva Pharmaceutical Industries Limited Shares Sold by Private Management Group Inc. | 02/06/2025 |
9 | Teva Pharmaceutical Industries Full Year 2024 Earnings EPS Misses Expectations | 02/07/2025 |
10 | Spotlight on Teva Pharmaceutical Indus Analyzing the Surge in Options Activity | 02/10/2025 |
11 | FMR LLC Increases Stake in Teva Pharmaceutical Industries Ltd | 02/12/2025 |
12 | Acquisition by Janet Vergis of 9632 shares of Teva Pharma subject to Rule 16b-3 | 02/14/2025 |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |